FDA Enforcement Class II Terminated

Choledochoscope Intended to provide optical visualization of and therapeutic access to the Biliary Tree. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Common Bile, Hepatic, Cystic and Pancreatic Ducts. The instrument is introduced via the working channel of a Duodenoscope positioned for access to the Common bile Duct when indications consistent with the need for procedure are observed in adult and pediatric patient populations.

Recall: Z-2067-2016 · Reported July 6, 2016

Enforcement

Recall Number
Z-2067-2016
Event ID
73894
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Pentax Medical Company
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 6, 2016
Initiation Date
April 6, 2016
Classification Date
June 28, 2016
Termination Date
December 21, 2017
Address
3 Paragon Dr, Montvale, NJ, 07645-1782, United States

Description

Choledochoscope Intended to provide optical visualization of and therapeutic access to the Biliary Tree. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Common Bile, Hepatic, Cystic and Pancreatic Ducts. The instrument is introduced via the working channel of a Duodenoscope positioned for access to the Common bile Duct when indications consistent with the need for procedure are observed in adult and pediatric patient populations.

Reason

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Code Info

Model #'s FCP-8P and FCP-9P

Distribution

Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam

Quantity

50 units